世界の脊椎装置&生物製剤市場予測 2023年-2029年

◆英語タイトル:Global Spinal Devices and Biologics Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23JU3888)◆商品コード:LP23JU3888
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年5月
◆ページ数:105
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療装置&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の脊椎装置&生物製剤市場」は、過去の販売実績から2022年の世界の脊椎装置&生物製剤の総販売量を検討し、2023年から2029年の予測される脊椎装置&生物製剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の脊椎装置&生物製剤の市場規模を掲載し、XXX百万米ドル規模の世界の脊椎装置&生物製剤市場の詳細な分析を提供します。本インサイトレポートは、世界の脊椎装置&生物製剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の脊椎装置&生物製剤市場における各社の独自のポジションをより深く理解するために、脊椎装置&生物製剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の脊椎装置&生物製剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。脊椎装置&生物製剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。脊椎装置&生物製剤の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。脊椎装置&生物製剤のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

脊椎装置&生物製剤の世界主要メーカーとしては、Nuvasive、 Orthofix International、 Exactech、 Wright Medical Group、 Johnson & Johnson、 Zimmer Biomet、 Globus Medical、 K2M、 Medtronic、 Alphatec Holdings、 RTI Surgicalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の脊椎装置&生物製剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では脊椎装置&生物製剤市場をセグメンテーションし、種類別 (脊椎結合/固定、可動性温存治療、非結合技術、骨折治療、その他)、用途別 (病院、外来手術センター、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:脊椎結合/固定、可動性温存治療、非結合技術、骨折治療、その他

・用途別区分:病院、外来手術センター、診療所、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の脊椎装置&生物製剤市場の10年間の市場状況・展望は?
・世界および地域別に見た脊椎装置&生物製剤市場成長の要因は何か?
・脊椎装置&生物製剤の市場機会はエンドマーケットの規模によってどのように変化するのか?
・脊椎装置&生物製剤のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:脊椎装置&生物製剤の年間販売量2018-2029、地域別現状・将来分析
・脊椎装置&生物製剤の種類別セグメント:脊椎結合/固定、可動性温存治療、非結合技術、骨折治療、その他
・脊椎装置&生物製剤の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・脊椎装置&生物製剤の用途別セグメント:病院、外来手術センター、診療所、その他
・脊椎装置&生物製剤の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の脊椎装置&生物製剤市場
・企業別のグローバル脊椎装置&生物製剤市場データ:2018-2023年の年間販売量、市場シェア
・企業別の脊椎装置&生物製剤の年間売上:2018-2023年の売上、市場シェア
・企業別の脊椎装置&生物製剤販売価格
・主要企業の脊椎装置&生物製剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

脊椎装置&生物製剤の地域別レビュー
・地域別の脊椎装置&生物製剤市場規模2018-2023:年間販売量、売上
・主要国別の脊椎装置&生物製剤市場規模2018-2023:年間販売量、売上
・南北アメリカの脊椎装置&生物製剤販売の成長
・アジア太平洋の脊椎装置&生物製剤販売の成長
・ヨーロッパの脊椎装置&生物製剤販売の成長
・中東・アフリカの脊椎装置&生物製剤販売の成長

南北アメリカ市場
・南北アメリカの国別の脊椎装置&生物製剤販売量、売上(2018-2023)
・南北アメリカの脊椎装置&生物製剤の種類別販売量
・南北アメリカの脊椎装置&生物製剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の脊椎装置&生物製剤販売量、売上(2018-2023)
・アジア太平洋の脊椎装置&生物製剤の種類別販売量
・アジア太平洋の脊椎装置&生物製剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の脊椎装置&生物製剤販売量、売上(2018-2023)
・ヨーロッパの脊椎装置&生物製剤の種類別販売量
・ヨーロッパの脊椎装置&生物製剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の脊椎装置&生物製剤販売量、売上(2018-2023)
・中東・アフリカの脊椎装置&生物製剤の種類別販売量
・中東・アフリカの脊椎装置&生物製剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・脊椎装置&生物製剤の製造コスト構造分析
・脊椎装置&生物製剤の製造プロセス分析
・脊椎装置&生物製剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・脊椎装置&生物製剤の主要なグローバル販売業者
・脊椎装置&生物製剤の主要なグローバル顧客

地域別の脊椎装置&生物製剤市場予測レビュー
・地域別の脊椎装置&生物製剤市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・脊椎装置&生物製剤の種類別市場規模予測
・脊椎装置&生物製剤の用途別市場規模予測

主要企業分析
Nuvasive、 Orthofix International、 Exactech、 Wright Medical Group、 Johnson & Johnson、 Zimmer Biomet、 Globus Medical、 K2M、 Medtronic、 Alphatec Holdings、 RTI Surgical
・企業情報
・脊椎装置&生物製剤製品
・脊椎装置&生物製剤販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Spinal Devices and Biologics Industry Forecast” looks at past sales and reviews total world Spinal Devices and Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Spinal Devices and Biologics sales for 2023 through 2029. With Spinal Devices and Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Spinal Devices and Biologics industry.
This Insight Report provides a comprehensive analysis of the global Spinal Devices and Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Spinal Devices and Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Spinal Devices and Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Spinal Devices and Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Spinal Devices and Biologics.
The global Spinal Devices and Biologics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Spinal Devices and Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Spinal Devices and Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Spinal Devices and Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Spinal Devices and Biologics players cover Nuvasive, Orthofix International, Exactech, Wright Medical Group, Johnson & Johnson, Zimmer Biomet, Globus Medical, K2M and Medtronic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Spinal Devices and Biologics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Spinal Fusion & Fixation
Motion Preservation
Non-Fusion Technologies
Fracture Treatment
Others
Segmentation by application
Hospitals
Ambulatory Surgical Centers
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Nuvasive
Orthofix International
Exactech
Wright Medical Group
Johnson & Johnson
Zimmer Biomet
Globus Medical
K2M
Medtronic
Alphatec Holdings
RTI Surgical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Spinal Devices and Biologics market?
What factors are driving Spinal Devices and Biologics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Spinal Devices and Biologics market opportunities vary by end market size?
How does Spinal Devices and Biologics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Spinal Devices and Biologics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Spinal Devices and Biologics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Spinal Devices and Biologics by Country/Region, 2018, 2022 & 2029
2.2 Spinal Devices and Biologics Segment by Type
2.2.1 Spinal Fusion & Fixation
2.2.2 Motion Preservation
2.2.3 Non-Fusion Technologies
2.2.4 Fracture Treatment
2.2.5 Others
2.3 Spinal Devices and Biologics Sales by Type
2.3.1 Global Spinal Devices and Biologics Sales Market Share by Type (2018-2023)
2.3.2 Global Spinal Devices and Biologics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Spinal Devices and Biologics Sale Price by Type (2018-2023)
2.4 Spinal Devices and Biologics Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Clinics
2.4.4 Others
2.5 Spinal Devices and Biologics Sales by Application
2.5.1 Global Spinal Devices and Biologics Sale Market Share by Application (2018-2023)
2.5.2 Global Spinal Devices and Biologics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Spinal Devices and Biologics Sale Price by Application (2018-2023)
3 Global Spinal Devices and Biologics by Company
3.1 Global Spinal Devices and Biologics Breakdown Data by Company
3.1.1 Global Spinal Devices and Biologics Annual Sales by Company (2018-2023)
3.1.2 Global Spinal Devices and Biologics Sales Market Share by Company (2018-2023)
3.2 Global Spinal Devices and Biologics Annual Revenue by Company (2018-2023)
3.2.1 Global Spinal Devices and Biologics Revenue by Company (2018-2023)
3.2.2 Global Spinal Devices and Biologics Revenue Market Share by Company (2018-2023)
3.3 Global Spinal Devices and Biologics Sale Price by Company
3.4 Key Manufacturers Spinal Devices and Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Spinal Devices and Biologics Product Location Distribution
3.4.2 Players Spinal Devices and Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Spinal Devices and Biologics by Geographic Region
4.1 World Historic Spinal Devices and Biologics Market Size by Geographic Region (2018-2023)
4.1.1 Global Spinal Devices and Biologics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Spinal Devices and Biologics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Spinal Devices and Biologics Market Size by Country/Region (2018-2023)
4.2.1 Global Spinal Devices and Biologics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Spinal Devices and Biologics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Spinal Devices and Biologics Sales Growth
4.4 APAC Spinal Devices and Biologics Sales Growth
4.5 Europe Spinal Devices and Biologics Sales Growth
4.6 Middle East & Africa Spinal Devices and Biologics Sales Growth
5 Americas
5.1 Americas Spinal Devices and Biologics Sales by Country
5.1.1 Americas Spinal Devices and Biologics Sales by Country (2018-2023)
5.1.2 Americas Spinal Devices and Biologics Revenue by Country (2018-2023)
5.2 Americas Spinal Devices and Biologics Sales by Type
5.3 Americas Spinal Devices and Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Spinal Devices and Biologics Sales by Region
6.1.1 APAC Spinal Devices and Biologics Sales by Region (2018-2023)
6.1.2 APAC Spinal Devices and Biologics Revenue by Region (2018-2023)
6.2 APAC Spinal Devices and Biologics Sales by Type
6.3 APAC Spinal Devices and Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Spinal Devices and Biologics by Country
7.1.1 Europe Spinal Devices and Biologics Sales by Country (2018-2023)
7.1.2 Europe Spinal Devices and Biologics Revenue by Country (2018-2023)
7.2 Europe Spinal Devices and Biologics Sales by Type
7.3 Europe Spinal Devices and Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Spinal Devices and Biologics by Country
8.1.1 Middle East & Africa Spinal Devices and Biologics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Spinal Devices and Biologics Revenue by Country (2018-2023)
8.2 Middle East & Africa Spinal Devices and Biologics Sales by Type
8.3 Middle East & Africa Spinal Devices and Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Spinal Devices and Biologics
10.3 Manufacturing Process Analysis of Spinal Devices and Biologics
10.4 Industry Chain Structure of Spinal Devices and Biologics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Spinal Devices and Biologics Distributors
11.3 Spinal Devices and Biologics Customer
12 World Forecast Review for Spinal Devices and Biologics by Geographic Region
12.1 Global Spinal Devices and Biologics Market Size Forecast by Region
12.1.1 Global Spinal Devices and Biologics Forecast by Region (2024-2029)
12.1.2 Global Spinal Devices and Biologics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Spinal Devices and Biologics Forecast by Type
12.7 Global Spinal Devices and Biologics Forecast by Application
13 Key Players Analysis
13.1 Nuvasive
13.1.1 Nuvasive Company Information
13.1.2 Nuvasive Spinal Devices and Biologics Product Portfolios and Specifications
13.1.3 Nuvasive Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Nuvasive Main Business Overview
13.1.5 Nuvasive Latest Developments
13.2 Orthofix International
13.2.1 Orthofix International Company Information
13.2.2 Orthofix International Spinal Devices and Biologics Product Portfolios and Specifications
13.2.3 Orthofix International Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Orthofix International Main Business Overview
13.2.5 Orthofix International Latest Developments
13.3 Exactech
13.3.1 Exactech Company Information
13.3.2 Exactech Spinal Devices and Biologics Product Portfolios and Specifications
13.3.3 Exactech Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Exactech Main Business Overview
13.3.5 Exactech Latest Developments
13.4 Wright Medical Group
13.4.1 Wright Medical Group Company Information
13.4.2 Wright Medical Group Spinal Devices and Biologics Product Portfolios and Specifications
13.4.3 Wright Medical Group Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Wright Medical Group Main Business Overview
13.4.5 Wright Medical Group Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Spinal Devices and Biologics Product Portfolios and Specifications
13.5.3 Johnson & Johnson Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Zimmer Biomet
13.6.1 Zimmer Biomet Company Information
13.6.2 Zimmer Biomet Spinal Devices and Biologics Product Portfolios and Specifications
13.6.3 Zimmer Biomet Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Zimmer Biomet Main Business Overview
13.6.5 Zimmer Biomet Latest Developments
13.7 Globus Medical
13.7.1 Globus Medical Company Information
13.7.2 Globus Medical Spinal Devices and Biologics Product Portfolios and Specifications
13.7.3 Globus Medical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Globus Medical Main Business Overview
13.7.5 Globus Medical Latest Developments
13.8 K2M
13.8.1 K2M Company Information
13.8.2 K2M Spinal Devices and Biologics Product Portfolios and Specifications
13.8.3 K2M Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 K2M Main Business Overview
13.8.5 K2M Latest Developments
13.9 Medtronic
13.9.1 Medtronic Company Information
13.9.2 Medtronic Spinal Devices and Biologics Product Portfolios and Specifications
13.9.3 Medtronic Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Medtronic Main Business Overview
13.9.5 Medtronic Latest Developments
13.10 Alphatec Holdings
13.10.1 Alphatec Holdings Company Information
13.10.2 Alphatec Holdings Spinal Devices and Biologics Product Portfolios and Specifications
13.10.3 Alphatec Holdings Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Alphatec Holdings Main Business Overview
13.10.5 Alphatec Holdings Latest Developments
13.11 RTI Surgical
13.11.1 RTI Surgical Company Information
13.11.2 RTI Surgical Spinal Devices and Biologics Product Portfolios and Specifications
13.11.3 RTI Surgical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 RTI Surgical Main Business Overview
13.11.5 RTI Surgical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Spinal Devices and Biologics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Spinal Devices and Biologics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Spinal Fusion & Fixation
Table 4. Major Players of Motion Preservation
Table 5. Major Players of Non-Fusion Technologies
Table 6. Major Players of Fracture Treatment
Table 7. Major Players of Others
Table 8. Global Spinal Devices and Biologics Sales by Type (2018-2023) & (K Units)
Table 9. Global Spinal Devices and Biologics Sales Market Share by Type (2018-2023)
Table 10. Global Spinal Devices and Biologics Revenue by Type (2018-2023) & ($ million)
Table 11. Global Spinal Devices and Biologics Revenue Market Share by Type (2018-2023)
Table 12. Global Spinal Devices and Biologics Sale Price by Type (2018-2023) & (USD/Unit)
Table 13. Global Spinal Devices and Biologics Sales by Application (2018-2023) & (K Units)
Table 14. Global Spinal Devices and Biologics Sales Market Share by Application (2018-2023)
Table 15. Global Spinal Devices and Biologics Revenue by Application (2018-2023)
Table 16. Global Spinal Devices and Biologics Revenue Market Share by Application (2018-2023)
Table 17. Global Spinal Devices and Biologics Sale Price by Application (2018-2023) & (USD/Unit)
Table 18. Global Spinal Devices and Biologics Sales by Company (2018-2023) & (K Units)
Table 19. Global Spinal Devices and Biologics Sales Market Share by Company (2018-2023)
Table 20. Global Spinal Devices and Biologics Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Spinal Devices and Biologics Revenue Market Share by Company (2018-2023)
Table 22. Global Spinal Devices and Biologics Sale Price by Company (2018-2023) & (USD/Unit)
Table 23. Key Manufacturers Spinal Devices and Biologics Producing Area Distribution and Sales Area
Table 24. Players Spinal Devices and Biologics Products Offered
Table 25. Spinal Devices and Biologics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Spinal Devices and Biologics Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Spinal Devices and Biologics Sales Market Share Geographic Region (2018-2023)
Table 30. Global Spinal Devices and Biologics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Spinal Devices and Biologics Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Spinal Devices and Biologics Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Spinal Devices and Biologics Sales Market Share by Country/Region (2018-2023)
Table 34. Global Spinal Devices and Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Spinal Devices and Biologics Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Spinal Devices and Biologics Sales by Country (2018-2023) & (K Units)
Table 37. Americas Spinal Devices and Biologics Sales Market Share by Country (2018-2023)
Table 38. Americas Spinal Devices and Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Spinal Devices and Biologics Revenue Market Share by Country (2018-2023)
Table 40. Americas Spinal Devices and Biologics Sales by Type (2018-2023) & (K Units)
Table 41. Americas Spinal Devices and Biologics Sales by Application (2018-2023) & (K Units)
Table 42. APAC Spinal Devices and Biologics Sales by Region (2018-2023) & (K Units)
Table 43. APAC Spinal Devices and Biologics Sales Market Share by Region (2018-2023)
Table 44. APAC Spinal Devices and Biologics Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Spinal Devices and Biologics Revenue Market Share by Region (2018-2023)
Table 46. APAC Spinal Devices and Biologics Sales by Type (2018-2023) & (K Units)
Table 47. APAC Spinal Devices and Biologics Sales by Application (2018-2023) & (K Units)
Table 48. Europe Spinal Devices and Biologics Sales by Country (2018-2023) & (K Units)
Table 49. Europe Spinal Devices and Biologics Sales Market Share by Country (2018-2023)
Table 50. Europe Spinal Devices and Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Spinal Devices and Biologics Revenue Market Share by Country (2018-2023)
Table 52. Europe Spinal Devices and Biologics Sales by Type (2018-2023) & (K Units)
Table 53. Europe Spinal Devices and Biologics Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Spinal Devices and Biologics Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Spinal Devices and Biologics Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Spinal Devices and Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Spinal Devices and Biologics Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Spinal Devices and Biologics Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Spinal Devices and Biologics Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Spinal Devices and Biologics
Table 61. Key Market Challenges & Risks of Spinal Devices and Biologics
Table 62. Key Industry Trends of Spinal Devices and Biologics
Table 63. Spinal Devices and Biologics Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Spinal Devices and Biologics Distributors List
Table 66. Spinal Devices and Biologics Customer List
Table 67. Global Spinal Devices and Biologics Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Spinal Devices and Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Spinal Devices and Biologics Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Spinal Devices and Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Spinal Devices and Biologics Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Spinal Devices and Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Spinal Devices and Biologics Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Spinal Devices and Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Spinal Devices and Biologics Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Spinal Devices and Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Spinal Devices and Biologics Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Spinal Devices and Biologics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Spinal Devices and Biologics Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Spinal Devices and Biologics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Nuvasive Basic Information, Spinal Devices and Biologics Manufacturing Base, Sales Area and Its Competitors
Table 82. Nuvasive Spinal Devices and Biologics Product Portfolios and Specifications
Table 83. Nuvasive Spinal Devices and Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 84. Nuvasive Main Business
Table 85. Nuvasive Latest Developments
Table 86. Orthofix International Basic Information, Spinal Devices and Biologics Manufacturing Base, Sales Area and Its Competitors
Table 87. Orthofix International Spinal Devices and Biologics Product Portfolios and Specifications
Table 88. Orthofix International Spinal Devices and Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 89. Orthofix International Main Business
Table 90. Orthofix International Latest Developments
Table 91. Exactech Basic Information, Spinal Devices and Biologics Manufacturing Base, Sales Area and Its Competitors
Table 92. Exactech Spinal Devices and Biologics Product Portfolios and Specifications
Table 93. Exactech Spinal Devices and Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 94. Exactech Main Business
Table 95. Exactech Latest Developments
Table 96. Wright Medical Group Basic Information, Spinal Devices and Biologics Manufacturing Base, Sales Area and Its Competitors
Table 97. Wright Medical Group Spinal Devices and Biologics Product Portfolios and Specifications
Table 98. Wright Medical Group Spinal Devices and Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 99. Wright Medical Group Main Business
Table 100. Wright Medical Group Latest Developments
Table 101. Johnson & Johnson Basic Information, Spinal Devices and Biologics Manufacturing Base, Sales Area and Its Competitors
Table 102. Johnson & Johnson Spinal Devices and Biologics Product Portfolios and Specifications
Table 103. Johnson & Johnson Spinal Devices and Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 104. Johnson & Johnson Main Business
Table 105. Johnson & Johnson Latest Developments
Table 106. Zimmer Biomet Basic Information, Spinal Devices and Biologics Manufacturing Base, Sales Area and Its Competitors
Table 107. Zimmer Biomet Spinal Devices and Biologics Product Portfolios and Specifications
Table 108. Zimmer Biomet Spinal Devices and Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 109. Zimmer Biomet Main Business
Table 110. Zimmer Biomet Latest Developments
Table 111. Globus Medical Basic Information, Spinal Devices and Biologics Manufacturing Base, Sales Area and Its Competitors
Table 112. Globus Medical Spinal Devices and Biologics Product Portfolios and Specifications
Table 113. Globus Medical Spinal Devices and Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 114. Globus Medical Main Business
Table 115. Globus Medical Latest Developments
Table 116. K2M Basic Information, Spinal Devices and Biologics Manufacturing Base, Sales Area and Its Competitors
Table 117. K2M Spinal Devices and Biologics Product Portfolios and Specifications
Table 118. K2M Spinal Devices and Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 119. K2M Main Business
Table 120. K2M Latest Developments
Table 121. Medtronic Basic Information, Spinal Devices and Biologics Manufacturing Base, Sales Area and Its Competitors
Table 122. Medtronic Spinal Devices and Biologics Product Portfolios and Specifications
Table 123. Medtronic Spinal Devices and Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 124. Medtronic Main Business
Table 125. Medtronic Latest Developments
Table 126. Alphatec Holdings Basic Information, Spinal Devices and Biologics Manufacturing Base, Sales Area and Its Competitors
Table 127. Alphatec Holdings Spinal Devices and Biologics Product Portfolios and Specifications
Table 128. Alphatec Holdings Spinal Devices and Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 129. Alphatec Holdings Main Business
Table 130. Alphatec Holdings Latest Developments
Table 131. RTI Surgical Basic Information, Spinal Devices and Biologics Manufacturing Base, Sales Area and Its Competitors
Table 132. RTI Surgical Spinal Devices and Biologics Product Portfolios and Specifications
Table 133. RTI Surgical Spinal Devices and Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 134. RTI Surgical Main Business
Table 135. RTI Surgical Latest Developments
List of Figures
Figure 1. Picture of Spinal Devices and Biologics
Figure 2. Spinal Devices and Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Spinal Devices and Biologics Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Spinal Devices and Biologics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Spinal Devices and Biologics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Spinal Fusion & Fixation
Figure 10. Product Picture of Motion Preservation
Figure 11. Product Picture of Non-Fusion Technologies
Figure 12. Product Picture of Fracture Treatment
Figure 13. Product Picture of Others
Figure 14. Global Spinal Devices and Biologics Sales Market Share by Type in 2022
Figure 15. Global Spinal Devices and Biologics Revenue Market Share by Type (2018-2023)
Figure 16. Spinal Devices and Biologics Consumed in Hospitals
Figure 17. Global Spinal Devices and Biologics Market: Hospitals (2018-2023) & (K Units)
Figure 18. Spinal Devices and Biologics Consumed in Ambulatory Surgical Centers
Figure 19. Global Spinal Devices and Biologics Market: Ambulatory Surgical Centers (2018-2023) & (K Units)
Figure 20. Spinal Devices and Biologics Consumed in Clinics
Figure 21. Global Spinal Devices and Biologics Market: Clinics (2018-2023) & (K Units)
Figure 22. Spinal Devices and Biologics Consumed in Others
Figure 23. Global Spinal Devices and Biologics Market: Others (2018-2023) & (K Units)
Figure 24. Global Spinal Devices and Biologics Sales Market Share by Application (2022)
Figure 25. Global Spinal Devices and Biologics Revenue Market Share by Application in 2022
Figure 26. Spinal Devices and Biologics Sales Market by Company in 2022 (K Units)
Figure 27. Global Spinal Devices and Biologics Sales Market Share by Company in 2022
Figure 28. Spinal Devices and Biologics Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Spinal Devices and Biologics Revenue Market Share by Company in 2022
Figure 30. Global Spinal Devices and Biologics Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Spinal Devices and Biologics Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Spinal Devices and Biologics Sales 2018-2023 (K Units)
Figure 33. Americas Spinal Devices and Biologics Revenue 2018-2023 ($ Millions)
Figure 34. APAC Spinal Devices and Biologics Sales 2018-2023 (K Units)
Figure 35. APAC Spinal Devices and Biologics Revenue 2018-2023 ($ Millions)
Figure 36. Europe Spinal Devices and Biologics Sales 2018-2023 (K Units)
Figure 37. Europe Spinal Devices and Biologics Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Spinal Devices and Biologics Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Spinal Devices and Biologics Revenue 2018-2023 ($ Millions)
Figure 40. Americas Spinal Devices and Biologics Sales Market Share by Country in 2022
Figure 41. Americas Spinal Devices and Biologics Revenue Market Share by Country in 2022
Figure 42. Americas Spinal Devices and Biologics Sales Market Share by Type (2018-2023)
Figure 43. Americas Spinal Devices and Biologics Sales Market Share by Application (2018-2023)
Figure 44. United States Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Spinal Devices and Biologics Sales Market Share by Region in 2022
Figure 49. APAC Spinal Devices and Biologics Revenue Market Share by Regions in 2022
Figure 50. APAC Spinal Devices and Biologics Sales Market Share by Type (2018-2023)
Figure 51. APAC Spinal Devices and Biologics Sales Market Share by Application (2018-2023)
Figure 52. China Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Spinal Devices and Biologics Sales Market Share by Country in 2022
Figure 60. Europe Spinal Devices and Biologics Revenue Market Share by Country in 2022
Figure 61. Europe Spinal Devices and Biologics Sales Market Share by Type (2018-2023)
Figure 62. Europe Spinal Devices and Biologics Sales Market Share by Application (2018-2023)
Figure 63. Germany Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Spinal Devices and Biologics Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Spinal Devices and Biologics Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Spinal Devices and Biologics Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Spinal Devices and Biologics Sales Market Share by Application (2018-2023)
Figure 72. Egypt Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Spinal Devices and Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Spinal Devices and Biologics in 2022
Figure 78. Manufacturing Process Analysis of Spinal Devices and Biologics
Figure 79. Industry Chain Structure of Spinal Devices and Biologics
Figure 80. Channels of Distribution
Figure 81. Global Spinal Devices and Biologics Sales Market Forecast by Region (2024-2029)
Figure 82. Global Spinal Devices and Biologics Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Spinal Devices and Biologics Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Spinal Devices and Biologics Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Spinal Devices and Biologics Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Spinal Devices and Biologics Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の脊椎装置&生物製剤市場予測 2023年-2029年(Global Spinal Devices and Biologics Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆